Key result
Elevations in high-sensitivity cardiac troponin I or T were associated with higher mortality risk beyond comorbidity burden in older adults with diabetes (hs-cTnI HR 3.0; 95% CI 1.7-5.4).
Why the study?
Incorporating comorbidity burden to guide diabetes management in older adults remains challenging, and high-sensitivity cardiac troponins may improve risk monitoring.
Cohort (n=1,835)
Hazard Ratio: 3 (95% CI 1.7–5.4)
May refine mortality prognostication beyond comorbidities in older diabetic adults; hypothesis-generating and requires prospective validation.
OBJECTIVE: Incorporation of comorbidity burden to inform diabetes management in older adults remains challenging. High-sensitivity cardiac troponins are objective, quantifiable biomarkers that may improve risk monitoring in older adults. We assessed the associations of elevations in high-sensitivity cardiac troponin I (hs-cTnI) and T (hs-cTnT) with comorbidities and improvements in mortality risk stratification. RESEARCH DESIGN AND METHODS: We used logistic regression to examine associations of comorbidities with elevations in either troponin (≥85th percentile) among 1,835 participants in the Atherosclerosis Risk in Communities (ARIC) Study with diabetes (ages 67-89 years, 43% male, 31% black) at visit 5 (2011-2013). We used Cox models to compare associations of high cardiac troponins with mortality across comorbidity levels. RESULTS: Elevations in either troponin (≥9.4 ng/L for hs-cTnI, ≥25 ng/L for hs-cTnT) were associated with prevalent coronary heart disease, heart failure, chronic kidney disease, pulmonary disease, hypoglycemia, hypertension, dementia, and frailty. Over a median follow-up of 6.2 years (418 deaths), both high hs-cTnI and high hs-cTnT further stratified mortality risk beyond comorbidity levels; those with a high hs-cTnI or hs-cTnT and high comorbidity were at highest mortality risk. Even among those with low comorbidity, a high hs-cTnI (hazard ratio 3.0 [95% CI 1.7, 5.4]) or hs-cTnT (hazard ratio 3.3 [95% CI 1.8, 6.2]) was associated with elevated mortality. CONCLUSIONS: Many comorbidities were reflected by both hs-cTnI and hs-cTnT; elevations in either of the troponins were associated with higher mortality risk beyond comorbidity burden. High-sensitivity cardiac troponins may identify older adults at high mortality risk and be useful in guiding clinical care of older adults with diabetes.
No takes yet. Share an insight, caveat, or question.
Tang et al. (2020) conducted a cohort in Diabetes (n=1,835). Elevations in high-sensitivity cardiac troponin I (≥9.4 ng/L) or T (≥25 ng/L) vs. Low troponin levels was evaluated on Mortality (HR 3.0, 95% CI 1.7-5.4). Elevations in high-sensitivity cardiac troponin I or T were associated with higher mortality risk beyond comorbidity burden in older adults with diabetes (hs-cTnI HR 3.0; 95% CI 1.7-5.4).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: